Weight Regain After GLP-1 Discontinuation is Less Rapid in Real World: Hamlet Gasoyan, PhD
Cost and Coverage Issues Drive GLP-1 Discontinuation: Hamlet Gasoyan, PhD
Scaling Obesity Care With Equity in Mind: Jaime Almandoz, MD, MBA
Discussing Tirzepatide’s Rise in Diabetes, Obesity Care: Jaime Almandoz, MD, MBA
GLP-1 Agonists and the Gut-Brain Axis: A New Era in Obesity Management
Dr Ian Neeland Explores Semaglutide Alternatives and Strategies in Cases of Nonresponse
Jeff McIntyre Raises NASH Awareness Among Health Care Community
Dr Ian Neeland Discusses Uptick in Patients Seeking Semaglutide for Weight Loss
Dr Ian Neeland Explains Why Semaglutide Shortage Impacts Injectable and Not Oral Version
Dr Ian Neeland on Oral Semaglutide as a Backup Amid Injection Shortage
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence
The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies
Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care
The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)
Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape
An American Journal of Managed Care® Forum: Discussing the Expanding Targeted Therapy Options and Complexities in Metastatic HER2+ Breast Cancer Treatment
Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies
Managed Care Approaches to Individualize Treatment of Hereditary Angioedema
Prescription Digital Therapeutics in Schizophrenia: A Managed Care Perspective on Advancements
Navigating Innovations: A Managed Care Perspective Addressing the Economic Burden of Schizophrenia
From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care
The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes
Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies
Closing Gaps in CLL Care: Managed Care Insights and Strategies
Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists
Overview and Burden of Migraine
The Evolving Treatment Landscape of Migraine
The Role of the Pharmacist Migraine Management
Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care
New and Approved: FDA’s 2024 Drug Lineup
Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia